CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Corticosteroid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06150378
NCT06150378N/ACompleted

Comparison Between Platelet Rich Plasma and Corticosteroids for the Treatment of Rotator Cuff Tendinopathy Randomized Controlled Double Blind Clinical Trial

Hospital Italiano de Buenos Aires·interventional·Posted Nov 29, 2023·Updated Nov 29, 2023

In Brief

A clinical study evaluating Corticosteroid and Plathet rich plasma for Shoulder Tendinopaty. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to test if Plateth-rich plasma would provide improved pain relief and function in patients with rotator cuff tendinopathy compared to standard treatment of corticosterone injections. Researchers will compare a control group of patients treated with a corticosterone injection with a case group of patients treated with Plateth-rich plasma injection. The purpose of this study is to perform a double-blind randomized controlled trial, comparing PRP with corticosteroids to provide pain relief and improve function in patients with rotator cuff tendinopathy. The hypothesis of this study is that PRP would provide improved pain relief and function in patients with rotator cuff tendinopathy compared to standard treatment of CS injections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesArgentina
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 29, 2023
Enrollment StartSep 30, 2022
Primary CompletionAug 1, 2023
Study CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.6 years ago

Interventions

Corticosteroiddrug

Patients that receive an injection with corticosteroid

Plathet rich plasmabiological

Patients that receive an injection with Plathet-rich plasma